vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and PEOPLES BANCORP OF NORTH CAROLINA INC (PEBK). Click either name above to swap in a different company.
PEOPLES BANCORP OF NORTH CAROLINA INC is the larger business by last-quarter revenue ($21.5M vs $13.8M, roughly 1.6× Gossamer Bio, Inc.). PEOPLES BANCORP OF NORTH CAROLINA INC runs the higher net margin — 30.8% vs -342.3%, a 373.1% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 5.6%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
PEOPLES BANCORP OF NORTH CAROLINA INC is a regional bank holding company headquartered in North Carolina, U.S. It offers a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving local residents, small and medium-sized enterprises, and community organizations across its operating areas in North Carolina.
GOSS vs PEBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $21.5M |
| Net Profit | $-47.2M | $6.6M |
| Gross Margin | — | — |
| Operating Margin | -333.6% | 40.7% |
| Net Margin | -342.3% | 30.8% |
| Revenue YoY | 47.1% | 5.6% |
| Net Profit YoY | -43.0% | 86.4% |
| EPS (diluted) | $-0.21 | $1.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $21.5M | ||
| Q3 25 | $13.3M | $21.4M | ||
| Q2 25 | — | $20.7M | ||
| Q1 25 | — | $20.0M | ||
| Q4 24 | — | $20.4M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | $95.8M | $20.1M | ||
| Q1 24 | $0 | $19.8M |
| Q4 25 | $-47.2M | $6.6M | ||
| Q3 25 | $-48.2M | $3.7M | ||
| Q2 25 | — | $5.2M | ||
| Q1 25 | — | $4.3M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | $49.2M | $4.9M | ||
| Q1 24 | $-41.9M | $3.9M |
| Q4 25 | -333.6% | 40.7% | ||
| Q3 25 | -369.4% | 22.4% | ||
| Q2 25 | — | 32.2% | ||
| Q1 25 | — | 28.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | — | 26.0% | ||
| Q2 24 | 54.3% | 31.3% | ||
| Q1 24 | — | 23.9% |
| Q4 25 | -342.3% | 30.8% | ||
| Q3 25 | -362.7% | 17.2% | ||
| Q2 25 | — | 24.9% | ||
| Q1 25 | — | 21.8% | ||
| Q4 24 | — | 17.5% | ||
| Q3 24 | — | 19.3% | ||
| Q2 24 | 51.4% | 24.4% | ||
| Q1 24 | — | 19.9% |
| Q4 25 | $-0.21 | $1.21 | ||
| Q3 25 | $-0.21 | $0.67 | ||
| Q2 25 | — | $0.95 | ||
| Q1 25 | — | $0.79 | ||
| Q4 24 | — | $0.65 | ||
| Q3 24 | — | $0.72 | ||
| Q2 24 | $0.22 | $0.89 | ||
| Q1 24 | $-0.19 | $0.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $58.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-122.8M | $157.1M |
| Total Assets | $172.2M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $58.1M | ||
| Q3 25 | $180.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $59.3M | ||
| Q3 24 | — | $73.2M | ||
| Q2 24 | $354.5M | — | ||
| Q1 24 | $244.4M | — |
| Q4 25 | $-122.8M | $157.1M | ||
| Q3 25 | $-82.3M | $149.5M | ||
| Q2 25 | — | $144.0M | ||
| Q1 25 | — | $138.5M | ||
| Q4 24 | — | $130.6M | ||
| Q3 24 | — | $136.3M | ||
| Q2 24 | $81.5M | $124.3M | ||
| Q1 24 | $26.7M | $121.1M |
| Q4 25 | $172.2M | $1.7B | ||
| Q3 25 | $208.8M | $1.7B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | $373.4M | $1.7B | ||
| Q1 24 | $259.4M | $1.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $21.4M |
| Free Cash FlowOCF − Capex | — | $20.0M |
| FCF MarginFCF / Revenue | — | 92.7% |
| Capex IntensityCapex / Revenue | 0.0% | 6.6% |
| Cash ConversionOCF / Net Profit | — | 3.22× |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $21.4M | ||
| Q3 25 | $-36.2M | $4.7M | ||
| Q2 25 | — | $5.5M | ||
| Q1 25 | — | $5.9M | ||
| Q4 24 | — | $20.6M | ||
| Q3 24 | — | $4.9M | ||
| Q2 24 | $116.3M | $6.7M | ||
| Q1 24 | $-52.3M | $3.7M |
| Q4 25 | — | $20.0M | ||
| Q3 25 | — | $4.4M | ||
| Q2 25 | — | $5.4M | ||
| Q1 25 | — | $5.2M | ||
| Q4 24 | — | $20.0M | ||
| Q3 24 | — | $4.7M | ||
| Q2 24 | — | $6.6M | ||
| Q1 24 | — | $3.5M |
| Q4 25 | — | 92.7% | ||
| Q3 25 | — | 20.4% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | — | 25.8% | ||
| Q4 24 | — | 98.0% | ||
| Q3 24 | — | 22.9% | ||
| Q2 24 | — | 32.7% | ||
| Q1 24 | — | 17.9% |
| Q4 25 | 0.0% | 6.6% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | 0.0% | 0.4% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | 3.22× | ||
| Q3 25 | — | 1.27× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | — | 1.36× | ||
| Q4 24 | — | 5.78× | ||
| Q3 24 | — | 1.24× | ||
| Q2 24 | 2.36× | 1.36× | ||
| Q1 24 | — | 0.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
